BlossomHill Therapeutics, Inc. ($BLSM)
Filing Information
| Accession Number | 0000947871-26-000785 |
|---|---|
| Form Type | 4 |
| Filing Date | Aug 12, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
4,803,558
Total Value
$10,000,000.00
P&L
+1.5% (+$150,000.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Aug 10, 2026 | Conversion | 1,039,996 | โ | โ | 1,039,996 | Indirect | See footnotes | View Details | |
Director | Common Stock | โ | Aug 10, 2026 | Conversion | 1,049,283 | โ | โ | 2,089,279 | Indirect | See footnotes | View Details | |
Director | Common Stock | โ | Aug 10, 2026 | Purchase | 625,000 | $16.00 | $10,000,000.00 | 2,714,279 | Indirect | See footnotes | View Details | |
Director | Series A Preferred Stock | Derivative | Aug 10, 2026 | Conversion | 1,039,996 | $0.00 | $0.00 | 0 | Indirect | See footnotes | View Details | |
Director | Series B Preferred Stock | Derivative | Aug 10, 2026 | Conversion | 1,049,283 | $0.00 | $0.00 | 0 | Indirect | See footnotes | View Details |